[Expressions of SOCS in chondrocytes of patients with osteoarthritis]

Area of Science:

• Molecular Biology
• Immunology
• Cell Biology

Background:

• Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown.
• Cytokine signaling pathways play a crucial role in the pathogenesis of OA.
• Suppressors of cytokine signaling (SOCS) proteins and cytokine-inducible SH2-domain 1 (CIS-1) are key regulators of cytokine signaling.

Purpose of the Study:

• To investigate the gene expression levels of SOCS1, SOCS2, SOCS3, and CIS-1 in chondrocytes from OA patients and healthy controls.
• To analyze the impact of inflammatory cytokines, specifically IL-1β and TNF-α, on the mRNA expression of these SOCS family members in chondrocytes.

Main Methods:

• Chondrocytes were isolated from OA patients and healthy individuals.
• Messenger RNA (mRNA) levels of SOCS1, SOCS2, SOCS3, and CIS-1 were quantified using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR).
• Healthy chondrocytes were cultured and treated with IL-1β, oncostatin M (OSM), or TNF-α to assess their effects on SOCS and CIS-1 mRNA expression.

Main Results:

• SOCS2 and CIS-1 mRNA levels were significantly reduced (approximately 8-fold) in chondrocytes from OA patients compared to controls.
• SOCS1 and SOCS3 mRNA expression levels were comparable between OA and control chondrocytes.
• Long-term exposure to inflammatory cytokines (IL-1β with OSM or TNF-α) led to a significant decrease in SOCS2 (5-fold) and CIS-1 (3-fold) mRNA levels.

Conclusions:

• The expression of SOCS2 and CIS-1 is downregulated in chondrocytes of osteoarthritis patients.
• SOCS1 and SOCS3 expression remains unchanged in osteoarthritis chondrocytes.
• Chronic exposure to inflammatory cytokines, mimicking the OA environment, further attenuates SOCS2 and CIS-1 expression in chondrocytes, highlighting their potential role in OA pathology.